首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1519478

2024-2032 年按產品、技術、動物類型、疾病類型、最終用戶和地區分類的獸醫分子診斷市場報告

Veterinary Molecular Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2024-2032

出版日期: 2024年07月01日 | 出版商:

IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年，全球獸醫分子診斷市場規模達6.908億美元。大眾擴大接受寵物，分子診斷技術不斷進步，以及擴大實施嚴格的監管指南和品質控制標準以標準化獸醫實踐中的分子診斷測試，是推動獸醫分子診斷市場成長的一些主要因素。

獸醫分子診斷市場分析：

主要市場促進因素：寵物擁有量的增加是推動市場成長的重要因素之一。此外，對能夠快速準確地檢測動物傳染源、有助於防止疾病傳播給人類並保障公眾健康的分子診斷的需求不斷成長，正在推動市場的成長。

主要市場趨勢：在獸醫護理中擴大使用個人化醫療來客製化治療計劃和預測疾病易感性，這為整個市場創造了積極的前景。

競爭格局：一些領先的獸醫分子診斷公司包括 Biochek BV、bioMerieux SA、HealthGene Corporation、Heska Corporation、IDEXX Laboratories Inc.、INDICAL BIOSCIENCE GmbH、Ingenetix GmbH、NEOGEN Corporation、Qiagen NV、Thermo Fisher Scientific Inc.、Veteriary Molectix Inc. 和Zoetis Inc. 等。

地理趨勢：根據報告，北美佔據最大的市場佔有率。這可以歸因於大眾擴大收養寵物來享受陪伴。除此之外，分子診斷測試的價格不斷提高，使其成為更廣泛的獸醫實踐的可行選擇，也促進了市場的成長。

挑戰與機會：獸醫分子診斷的挑戰包括需要具有成本效益和使用者友好的技術，以及需要廣泛的驗證以確保不同動物物種的準確性。機會在於開發快速、即時診斷的檢測方法以及基於遺傳資訊的個人化治療計劃的潛力，從而推進動物保健。

獸醫分子診斷市場趨勢：

大眾擴大收養寵物

大眾越來越接受寵物，對獸醫分子診斷市場產生了積極影響。寵物擁有量的激增導致對包括診斷在內的獸醫服務的需求增加。例如，根據寵物食品製造商協會2021年3月公佈的寵物數量資料，英國超過59%的家庭養有寵物，2021年寵物數量將超過3260萬隻。反過來又增加了獸醫分子診斷市場的需求。此外，狗和貓是寵物父母收養的熱門寵物。例如，到 2022 年，狗的數量約為 6.045 億隻，而貓的數量約為 6.045 億隻。全球 4.082 億。除此之外，美國寵物產品協會在2022年4月發布的數據顯示，2021年美國寵物產業總支出達到1,236億美元，高於2020年的1,036億美元。的成長。

動物疾病盛行率上升

動物疾病盛行率的上升推動了獸醫分子診斷市場的成長。根據卡加利大學2021 年6 月發表的一項研究，該研究旨在調查家犬中多房棘球絛蟲的感染情況，以推斷其在人畜共患病傳播中的潛在作用，該研究指出，多房棘球絛蟲是北半球的一種寄生蠕蟲（加拿大艾伯塔省）），通常在最終宿主和中間宿主之間循環。但在城市地區，家養的狗也可能成為這種寄生蟲的宿主，由於它們距離很近，這可能成為人類的重大風險因素。除此之外，據估計，每年有五分之一的農場動物因疾病而死亡，還有更多的動物受到疾病的影響。根據新興病原體研究所2021年11月發表的文章，牛隻呼吸道疾病佔飼養場疾病的75%，每年造成養牛者的經濟損失超過10億美元。據估計，紅眼症每年造成的損失為 1.5 億美元，每隻動物因腐蹄病對乳製品生產商造成的損失為 120 美元至 350 美元。動物中這種不斷增加的損失和遺傳性疾病預計將推動對獸醫分子診斷的需求，從而擴大獸醫分子診斷的市場佔有率。

分子診斷技術不斷進步

分子診斷技術的不斷進步正在推動市場的成長。聚合酶鍊式反應 (PCR)、新一代定序 (NGS) 和微陣列分析等尖端分子診斷技術不斷發展，為獸醫提供有關動物健康的無與倫比的見解。此外，各個主要市場參與者正在推出改進的診斷套件和儀器，以促進高品質的診斷和治療。例如，2022 年 4 月，格林斯博羅的 Carolina Liquid Chemistries Corp 簽署了一項半獨家協議，為美國獸醫市場分銷攜帶式分析儀。該公司經銷 SeamatySMT-120 VP 獸醫自動化化學分析儀，這是一款緊湊型全自動化學、電解質免疫分析和凝血分析儀，用於動物健康診斷。同樣，2021 年 9 月，Micro Vet Diagnostics 推出了 Micro-chem II，這是一款用於動物健康的全新化學、電解質、免疫測定和凝血分析儀，可產生準確的參考和實驗室品質的結果。此類創新正在提高獸醫實驗室的效率，並縮短測試結果的周轉時間，預計這將在未來幾年推動獸醫分子診斷市場的收入。

市場結構
關鍵參與者
關鍵參與者簡介
- Biochek BV
- bioMerieux SA
- HealthGene Corporation
- Heska Corporation
- IDEXX Laboratories Inc.
- INDICAL BIOSCIENCE GmbH
- Ingenetix GmbH
- NEOGEN Corporation
- Qiagen NV
- Thermo Fisher Scientific Inc.
- Veterinary Molecular Diagnostics Inc.
- Zoetis Inc.

簡介目錄圖表

Product Code: SR112024A5121

The global veterinary molecular diagnostics market size reached US$ 690.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,391.9 Million by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032. The growing adoption of pets among the masses, increasing advancements in molecular diagnostic technologies, and rising implementation of stringent regulatory guidelines and quality control standards to standardize molecular diagnostic tests in veterinary practice are some of the major factors propelling the veterinary molecular diagnostics market growth.

Veterinary Molecular Diagnostics Market Analysis:

Major Market Drivers: Increasing pet ownership is one of the significant factors driving the growth of the market. Additionally, the rising demand for molecular diagnostics that can rapidly and accurately detect infectious agents in animals, helping to prevent disease transmission to humans and safeguard public health, is impelling the growth of the market.

Key Market Trends: The rising utilization of personalized medicine in veterinary care to tailor treatment plans and predict disease susceptibility is creating a positive outlook for the overall market.

Competitive Landscape: Some of the leading veterinary molecular diagnostics companies include Biochek B.V., bioMerieux SA, HealthGene Corporation, Heska Corporation, IDEXX Laboratories Inc., INDICAL BIOSCIENCE GmbH, Ingenetix GmbH, NEOGEN Corporation, Qiagen N.V, Thermo Fisher Scientific Inc., Veterinary Molecular Diagnostics Inc., and Zoetis Inc., among others.

Geographical Trends: According to the report, North America accounted for the largest market share. This can be attributed to the rising adoption of pets among the masses to enjoy their companionship. Besides this, the increasing affordability of molecular diagnostic tests, making them a viable option for a wider range of veterinary practices, is contributing to the growth of the market.

Challenges and Opportunities: Challenges in veterinary molecular diagnostics include the need for cost-effective and user-friendly technologies, as well as the requirement for extensive validation to ensure accuracy across diverse animal species. Opportunities lie in the development of rapid, point-of-care assays for timely diagnosis and the potential for personalized treatment plans based on genetic information, advancing animal health care.

Veterinary Molecular Diagnostics Market Trends:

Growing Adoption of Pets Among the Masses

The growing adoption of pets among the masses is positively influencing the veterinary molecular diagnostics market. This surge in pet ownership is resulting in a higher demand for veterinary services, including diagnostics. For instance, according to the pet population data published in March 2021 by the Pet Food Manufacturers Association, over 59% of households in the United Kingdom had pets, with over 32.6 million pets in 2021. The trend of treating pets as family members is growing, which in turn is augmenting the veterinary molecular diagnostics market demand. Moreover, dogs and cats are the popular pets adopted by pet parents. For instance, the dog population was around 604.5 million in 2022, whereas the cat population was approx. 408.2 million globally. Besides this, the American Pet Products Association published in April 2022 that the total American pet industry expenditure reached US$ 123.6 Billion in 2021, up from US$ 103.6 Billion in 2020. The rise in animal health expenditure is expected to drive the growth of the veterinary molecular diagnostics market, as a significant portion of pet owners are expected to use advanced diagnostic modalities for various disease conditions in animals and propel the veterinary molecular diagnostics market's recent price.

Rising Prevalence of Animal Diseases

The rising prevalence of animal diseases is bolstering the growth of the veterinary molecular diagnostics market. According to a study published by the University of Calgary in June 2021, conducted to investigate the infections of Echinococcus multilocularis in domestic dogs to infer their potential role in zoonotic transmission, stated that Echinococcus multilocularis, a parasitic helminth of the northern hemisphere (Alberta, Canada), normally cycles through definitive and intermediate hosts. But in urban areas, domestic dogs can also become hosts for this parasite, which could become a significant risk factor to humans due to their proximity. Besides this, it is estimated that one in five farm animals is lost due to diseases each year, while many more animals suffer the effects of illness. According to an article published by Emerging Pathogen Institutes in November 2021, bovine respiratory diseases account for 75% of feedlot illnesses, and economic losses to cattle producers exceed US$ 1 Billion every year. The estimated costs for pinkeye are US$ 150 Million yearly, and losses to dairy producers due to foot rot range from US$ 120 to US$ 350 per animal. Such increasing losses and genetic disorders among animals are expected to drive the demand for veterinary molecular diagnostics, thereby augmenting the veterinary molecular diagnostics market share.

Increasing Advancements in Molecular Diagnostic Technologies

The increasing advancements in molecular diagnostic technologies are bolstering the growth of the market. Cutting-edge molecular diagnostic technologies, such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarray analysis, are continually evolving to provide veterinarians with unparalleled insights into the health of animals. Moreover, various key market players are launching improved diagnostics kits and instruments to facilitate quality diagnosis and treatments. For instance, in April 2022, Carolina Liquid Chemistries Corp of Greensboro signed a semi-exclusive agreement to distribute a portable analyzer for the US veterinary market. The company distributed the SeamatySMT-120 VP veterinary automated chemistry analyzer, a compact, fully automatic chemistry, electrolyte immunoassay, and coagulation analyzer for animal health diagnosis. Similarly, in September 2021, Micro Vet Diagnostics launched Micro-chem II, a completely new chemistry, electrolyte, immunoassay, and coagulation analyzer for animal health, producing accurate reference and laboratory-quality results. Such innovations are enhancing the efficiency of veterinary laboratories and enabling quicker turnaround times for test results, which is anticipated to propel veterinary molecular diagnostics market revenue in the coming years.

Global Veterinary Molecular Diagnostics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, technology, animal type, disease type, and end user.

Breakup by Product:

Kits and Reagents

Instruments

Software and Services

Kits and reagents dominate the market

The veterinary molecular diagnostics market report has provided a detailed breakup and analysis of the market based on the product. This includes kits and reagents, instruments, and software and services. According to the report, kits and reagents represented the largest segment.

In veterinary molecular diagnostics, various kits and reagents are required to conduct tests and experiments to detect and analyze nucleic acids from animal samples. These molecular diagnostic tools are used for a wide range of purposes, including disease detection, genotyping, pathogen identification, and genetic research in animals. Kits and reagents for next-generation sequencing (NGS) are employed to characterize the genomes of pathogens, aiding in the study of their evolution, drug resistance, and virulence factors. They also enable the study of epigenetic modifications in animal DNA, providing insights into gene regulation and potential links between epigenetic changes and disease susceptibility.

Breakup by Technology:

Real Time PCR

Microarray

DNA Sequencing

Real time PCR holds the largest share in the market

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes real time PCR, microarray, and DNA sequencing. According to the report, real time PCR accounted for the largest market share.

Real-time PCR (Polymerase Chain Reaction) in Veterinary Molecular Diagnostics is a molecular biology technique used to amplify and quantify DNA in real-time during the PCR process. It is a sensitive and accurate method for measuring the amount of a target DNA or RNA molecule in a biological sample. Real-time PCR is widely employed to examine and quantify pathogens in animals, including viruses, bacteria, fungi, and parasites. It also allows for early and accurate diagnosis, enabling prompt treatment and disease management.

Breakup by Animal Type:

Companion Animal

Livestock Animal

Companion animal holds the biggest share in the market

A detailed breakup and analysis of the market based on the animal type have also been provided in the report. This includes companion animal and livestock animal. According to the report, companion animal accounted for the largest market share.

As per the veterinary molecular diagnostics market statistics by IMARC, the increasing trend of pet humanization is contributing to the growth of this segment. Companion animals, like dogs, cats, and other pets, require veterinary molecular diagnostics to detect diseases and health conditions. Some companion animals are prone to genetic disorders or inherited diseases. The rising pet ownership and growing consciousness of pet parents regarding the health of their pets are bolstering the market for molecular diagnostics. For instance, there are over 31 million pet dogs and around 2.44 million pet cats in India. The pet cat population may reach 4.89 million by 2026. 11% of people in India own at least four pets. Molecular diagnostics can identify genetic mutations or markers associated with these conditions, allowing breeders to make informed decisions about breeding and helping veterinarians manage the health of affected animals. Molecular tests can rapidly identify the presence of infectious agents, including viruses, bacteria, and parasites. This is crucial for diagnosing and managing diseases like parvovirus, feline leukemia, and Lyme disease.

Breakup by Disease Type:

Vector-borne Diseases

Respiratory Pathogens

Diarrhea Pathogens

Others

Vector-borne diseases hold the maximum share in the market

A detailed breakup and analysis of the market based on the disease type have also been provided in the report. This includes vector-borne diseases, respiratory pathogens, diarrhea pathogens, and others. According to the report, vector-borne diseases accounted for the largest market share.

Vector-borne diseases in animals are infections that are transmitted from one animal to another through the bites of arthropod vectors, similar to how these diseases are transmitted to humans. They can have significant economic impacts on agriculture and can reduce the productivity of livestock, decrease meat and milk production, and even lead to animal deaths. Molecular diagnostic methods, like PCR, swiftly and precisely identify the genetic material of pathogens causing vector-borne diseases in animals, crucial for efficient disease control. Such techniques aid in tracking disease advancement in infected animals, enabling veterinarians to gauge infection severity and adapt treatment strategies accordingly.

Breakup by End User:

Veterinary Hospitals

Clinical Laboratories

Research Institutes

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes veterinary hospitals, clinical laboratories, and research institutes.

The veterinary molecular diagnostics market overview indicates that veterinary molecular diagnostics plays a crucial role in veterinary hospitals by offering advanced tools and techniques for the monitoring and treatment of diseases in animals. They can be used in biosecurity protocols to quickly identify and isolate infected animals, preventing the spread of contagious diseases within veterinary hospitals and breeding facilities.

Veterinary molecular diagnostics plays a pivotal role in clinical laboratories dedicated to animal healthcare. These sophisticated techniques harness the power of molecular biology to provide rapid, precise, and comprehensive insights into the health of animals. Besides this, in research institutes focused on enhancing understanding of animal health, genetics, and disease mechanisms, veterinary molecular diagnostics is essential. Utilizing state-of-the-art molecular methods like Polymerase Chain Reaction (PCR), DNA sequencing, and genotyping, these institutes conduct diverse studies benefiting both animal and human welfare.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest veterinary molecular diagnostics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the rising adoption of pets among the masses to enjoy their companionship. For instance, according to pet ownership statistics by Forbes, pet ownership in the U.S. jumped significantly over the past three decades. As of 2024, 66% of U.S. households (86.9 million homes) own a pet. That is up from 56% in 1988. Moreover, the rise in the prevalence of animal diseases and injuries is also a major factor bolstering the market growth. According to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA), the annual expenditure on a routine visit for dogs accounts for US$ 242 and US$ 178 for cats in the country. Furthermore, the increasing affordability of molecular diagnostic tests, making them a viable option for a wider range of veterinary practices, is contributing to the growth of the market. Apart from this, the escalating number of product launches in North America that focus on molecular diagnostics for animals drives the market growth. For instance, in January 2022, IDEXX Laboratories, Inc. expanded its reference laboratory menu of tests and services that will enable veterinarians to better meet the challenges of diagnosing and treating cancer. Such activities are expected to positively impact the veterinary molecular diagnostics market outlook in the coming years.

Competitive Landscape:

Key market players are developing innovative and more accurate diagnostic tests for animals by creating new assays, improving the sensitivity and specificity of existing tests, and expanding their test menu to cover a broader range of diseases. They are also expanding their product portfolios to include a wider range of diagnostic tests for different animal species, including companion animals (dogs and cats), livestock (cattle, pigs, and poultry), and exotic animals. Top companies are establishing partnerships or collaborations with distributors and veterinary clinics in different regions to reach a global customer base. They are also incorporating automation and advanced technologies into their diagnostic platforms to streamline testing processes, reduce turnaround times, and enhance the accuracy of results.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Biochek B.V.

bioMerieux SA

HealthGene Corporation

Heska Corporation

IDEXX Laboratories Inc.

INDICAL BIOSCIENCE GmbH

Ingenetix GmbH

NEOGEN Corporation

Qiagen N.V

Thermo Fisher Scientific Inc.

Veterinary Molecular Diagnostics Inc.

Zoetis Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Veterinary Molecular Diagnostics Market Recent Developments:

May 2024: A molecular diagnostics startup, Fuse Diagnostics, announced the successful completion of an oversubscribed seed investment round in which it raised a total of 1.6 million pounds (US$ 2 Million) from a group of angel investors and the agency Innovate UK. Fuse is focused on the development of its Apex range, aimed at clinical diagnostics and veterinary applications.

February 2024: MiDOG Animal Diagnostics LLC, a prominent leader in microbiome-based veterinary diagnostic solutions employing Next Generation DNA Sequencing analysis, unveiled a revamped branding strategy in 2024. By extending its diagnostic capabilities to encompass a diverse range of animal species, MiDOG aims to equip veterinarians with the tools needed to address acute, chronic, and non-responsive infections effectively.

November 2023: Antech, the full-service veterinary diagnostics business that is part of the Science & Diagnostics division of Mars Petcare, announced the opening of a new UK veterinary diagnostics laboratory in Warwick. This expands Antech's UK lab network, which also includes Southfields Veterinary Specialists Diagnostic Laboratory and the Dick White Referrals Diagnostic Laboratory.

Key Questions Answered in This Report

1. What was the size of the global veterinary molecular diagnostics market in 2023?
2. What is the expected growth rate of the global veterinary molecular diagnostics market during 2024-2032?
3. What are the key factors driving the global veterinary molecular diagnostics market?
4. What has been the impact of COVID-19 on the global veterinary molecular diagnostics market?
5. What is the breakup of the global veterinary molecular diagnostics market based on the product?
6. What is the breakup of the global veterinary molecular diagnostics market based on the technology?
7. What is the breakup of the global veterinary molecular diagnostics market based on the animal type?
8. What is the breakup of the global veterinary molecular diagnostics market based on the disease type?
9. What are the key regions in the global veterinary molecular diagnostics market?
10. Who are the key players/companies in the global veterinary molecular diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Veterinary Molecular Diagnostics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Kits and Reagents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Technology

7.1 Real Time PCR
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Microarray
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 DNA Sequencing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Animal Type

8.1 Companion Animal
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Livestock Animal
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Disease Type

9.1 Vector-borne Diseases
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Respiratory Pathogens
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Diarrhea Pathogens
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by End User

10.1 Veterinary Hospitals
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Clinical Laboratories
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Research Institutes
- 10.3.1 Market Trends
- 10.3.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia-Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 Biochek B.V.
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
- 16.3.2 bioMerieux SA
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
  - 16.3.2.3 Financials
  - 16.3.2.4 SWOT Analysis
- 16.3.3 HealthGene Corporation
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
- 16.3.4 Heska Corporation
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
  - 16.3.4.3 Financials
  - 16.3.4.4 SWOT Analysis
- 16.3.5 IDEXX Laboratories Inc.
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
  - 16.3.5.3 Financials
  - 16.3.5.4 SWOT Analysis
- 16.3.6 INDICAL BIOSCIENCE GmbH
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
- 16.3.7 Ingenetix GmbH
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
- 16.3.8 NEOGEN Corporation
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials
  - 16.3.8.4 SWOT Analysis
- 16.3.9 Qiagen N.V
  - 16.3.9.1 Company Overview
  - 16.3.9.2 Product Portfolio
  - 16.3.9.3 Financials
  - 16.3.9.4 SWOT Analysis
- 16.3.10 Thermo Fisher Scientific Inc.
  - 16.3.10.1 Company Overview
  - 16.3.10.2 Product Portfolio
  - 16.3.10.3 Financials
  - 16.3.10.4 SWOT Analysis
- 16.3.11 Veterinary Molecular Diagnostics Inc.
  - 16.3.11.1 Company Overview
  - 16.3.11.2 Product Portfolio
- 16.3.12 Zoetis Inc.
  - 16.3.12.1 Company Overview
  - 16.3.12.2 Product Portfolio
  - 16.3.12.3 Financials
  - 16.3.12.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Veterinary Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Veterinary Molecular Diagnostics Market: Breakup by Product (in %), 2023
Figure 5: Global: Veterinary Molecular Diagnostics Market: Breakup by Technology (in %), 2023
Figure 6: Global: Veterinary Molecular Diagnostics Market: Breakup by Animal Type (in %), 2023
Figure 7: Global: Veterinary Molecular Diagnostics Market: Breakup by Disease Type (in %), 2023
Figure 8: Global: Veterinary Molecular Diagnostics Market: Breakup by End User (in %), 2023
Figure 9: Global: Veterinary Molecular Diagnostics Market: Breakup by Region (in %), 2023
Figure 10: Global: Veterinary Molecular Diagnostics (Kits and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Veterinary Molecular Diagnostics (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Veterinary Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Veterinary Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Veterinary Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Veterinary Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Veterinary Molecular Diagnostics (Real Time PCR) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Veterinary Molecular Diagnostics (Real Time PCR) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Veterinary Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Veterinary Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Veterinary Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Veterinary Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Veterinary Molecular Diagnostics (Companion Animal) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Veterinary Molecular Diagnostics (Companion Animal) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Veterinary Molecular Diagnostics (Livestock Animal) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Veterinary Molecular Diagnostics (Livestock Animal) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Veterinary Molecular Diagnostics (Vector-borne Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Veterinary Molecular Diagnostics (Vector-borne Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Veterinary Molecular Diagnostics (Respiratory Pathogens) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Veterinary Molecular Diagnostics (Respiratory Pathogens) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Veterinary Molecular Diagnostics (Diarrhea Pathogens) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Veterinary Molecular Diagnostics (Diarrhea Pathogens) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Veterinary Molecular Diagnostics (Other Disease Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Veterinary Molecular Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Veterinary Molecular Diagnostics (Veterinary Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Veterinary Molecular Diagnostics (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Veterinary Molecular Diagnostics (Clinical Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Veterinary Molecular Diagnostics (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Veterinary Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Veterinary Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: North America: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: North America: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: United States: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: United States: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Canada: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Canada: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Asia-Pacific: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Asia-Pacific: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: China: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: China: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Japan: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Japan: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: India: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: India: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: South Korea: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: South Korea: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Australia: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Australia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Indonesia: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Indonesia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Europe: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Europe: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Germany: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Germany: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: France: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: France: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: United Kingdom: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: United Kingdom: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Italy: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Italy: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Spain: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Spain: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Russia: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Russia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Latin America: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Latin America: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Brazil: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Brazil: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Mexico: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Mexico: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Middle East and Africa: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Middle East and Africa: Veterinary Molecular Diagnostics Market: Breakup by Country (in %), 2023
Figure 88: Middle East and Africa: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Global: Veterinary Molecular Diagnostics Industry: SWOT Analysis
Figure 90: Global: Veterinary Molecular Diagnostics Industry: Value Chain Analysis
Figure 91: Global: Veterinary Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Veterinary Molecular Diagnostics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 4: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Animal Type (in Million US$), 2024-2032
Table 5: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Disease Type (in Million US$), 2024-2032
Table 6: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 7: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Veterinary Molecular Diagnostics Market: Competitive Structure
Table 9: Global: Veterinary Molecular Diagnostics Market: Key Players

02-2729-4219

+886-2-2729-4219